Cargando…

Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year

BACKGROUND: The clinical benefit of percutaneous coronary intervention (PCI) for long coronary lesions is unclear; furthermore, concerns have been raised about its safety. OBJECTIVES: To evaluate the predictors of major adverse cardiac events (MACE) associated with PCI using a full metal jacket (FMJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Calé, Rita, Teles, Rui Campante, Almeida, Manuel, do Rosário, Ingrid, Sousa, Pedro Jerónimo, Brito, João, Raposo, Luís, Gonçalves, Pedro de Araújo, Gabriel, Henrique Mesquita, Mendes, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998154/
https://www.ncbi.nlm.nih.gov/pubmed/23821408
http://dx.doi.org/10.5935/abc.20130139
_version_ 1782313304356552704
author Calé, Rita
Teles, Rui Campante
Almeida, Manuel
do Rosário, Ingrid
Sousa, Pedro Jerónimo
Brito, João
Raposo, Luís
Gonçalves, Pedro de Araújo
Gabriel, Henrique Mesquita
Mendes, Miguel
author_facet Calé, Rita
Teles, Rui Campante
Almeida, Manuel
do Rosário, Ingrid
Sousa, Pedro Jerónimo
Brito, João
Raposo, Luís
Gonçalves, Pedro de Araújo
Gabriel, Henrique Mesquita
Mendes, Miguel
author_sort Calé, Rita
collection PubMed
description BACKGROUND: The clinical benefit of percutaneous coronary intervention (PCI) for long coronary lesions is unclear; furthermore, concerns have been raised about its safety. OBJECTIVES: To evaluate the predictors of major adverse cardiac events (MACE) associated with PCI using a full metal jacket (FMJ), defined as overlapping drug-eluting stents (DES) measuring > 60 mm in length, for very long lesions. METHODS: We enrolled 136 consecutive patients with long coronary lesions requiring FMJ in our single-center registry. The primary endpoint included the combined occurrence of all-cause death, myocardial infarction (MI), and target vessel revascularization (TVR). Demographic, clinical, angiographic, and procedural variables were evaluated using stepwise Cox regression analysis to determine independent predictors of outcome. RESULTS: The mean length of stent per lesion was 73.2 ± 12.3 mm and the mean reference vessel diameter was 2.9 ± 0.6 mm. Angiographic success was 96.3%. Freedom from MACE was 94.9% at 30 days and 85.3% at one year. At the one-year follow-up, the all-cause mortality rate was 3.7% (1.5% cardiac deaths), the MI rate was 3.7%, and the incidence of definite or probable stent thrombosis (ST) was 2.9%. Female gender [hazard ratio (HR), 4.40; 95% confidence interval (CI), 1.81-10.66; p = 0.001) and non-right coronary artery PCI (HR, 3.49; 95%CI, 1.42-8.59; p = 0,006) were independent predictors of MACE at one year. Freedom from adverse events at one year was higher in patients with stable angina who underwent PCI (HR, 0.33; 95%CI, 0.13-0.80; p = 0.014). CONCLUSIONS: PCI using FMJ with DES for very long lesions was efficacious but associated with a high rate of ST at the one-year follow-up. However, the rate of cardiac mortality, nonprocedure-related MI, and MACE was relatively low. Target coronary vessel PCI, clinical presentation, and female gender are new contemporary clinical factors that appear to have adverse effects on the outcome of PCI using FMJ for long lesions.
format Online
Article
Text
id pubmed-3998154
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Sociedade Brasileira de Cardiologia
record_format MEDLINE/PubMed
spelling pubmed-39981542014-05-08 Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year Calé, Rita Teles, Rui Campante Almeida, Manuel do Rosário, Ingrid Sousa, Pedro Jerónimo Brito, João Raposo, Luís Gonçalves, Pedro de Araújo Gabriel, Henrique Mesquita Mendes, Miguel Arq Bras Cardiol Original Article BACKGROUND: The clinical benefit of percutaneous coronary intervention (PCI) for long coronary lesions is unclear; furthermore, concerns have been raised about its safety. OBJECTIVES: To evaluate the predictors of major adverse cardiac events (MACE) associated with PCI using a full metal jacket (FMJ), defined as overlapping drug-eluting stents (DES) measuring > 60 mm in length, for very long lesions. METHODS: We enrolled 136 consecutive patients with long coronary lesions requiring FMJ in our single-center registry. The primary endpoint included the combined occurrence of all-cause death, myocardial infarction (MI), and target vessel revascularization (TVR). Demographic, clinical, angiographic, and procedural variables were evaluated using stepwise Cox regression analysis to determine independent predictors of outcome. RESULTS: The mean length of stent per lesion was 73.2 ± 12.3 mm and the mean reference vessel diameter was 2.9 ± 0.6 mm. Angiographic success was 96.3%. Freedom from MACE was 94.9% at 30 days and 85.3% at one year. At the one-year follow-up, the all-cause mortality rate was 3.7% (1.5% cardiac deaths), the MI rate was 3.7%, and the incidence of definite or probable stent thrombosis (ST) was 2.9%. Female gender [hazard ratio (HR), 4.40; 95% confidence interval (CI), 1.81-10.66; p = 0.001) and non-right coronary artery PCI (HR, 3.49; 95%CI, 1.42-8.59; p = 0,006) were independent predictors of MACE at one year. Freedom from adverse events at one year was higher in patients with stable angina who underwent PCI (HR, 0.33; 95%CI, 0.13-0.80; p = 0.014). CONCLUSIONS: PCI using FMJ with DES for very long lesions was efficacious but associated with a high rate of ST at the one-year follow-up. However, the rate of cardiac mortality, nonprocedure-related MI, and MACE was relatively low. Target coronary vessel PCI, clinical presentation, and female gender are new contemporary clinical factors that appear to have adverse effects on the outcome of PCI using FMJ for long lesions. Sociedade Brasileira de Cardiologia 2013-08 /pmc/articles/PMC3998154/ /pubmed/23821408 http://dx.doi.org/10.5935/abc.20130139 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Calé, Rita
Teles, Rui Campante
Almeida, Manuel
do Rosário, Ingrid
Sousa, Pedro Jerónimo
Brito, João
Raposo, Luís
Gonçalves, Pedro de Araújo
Gabriel, Henrique Mesquita
Mendes, Miguel
Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year
title Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year
title_full Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year
title_fullStr Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year
title_full_unstemmed Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year
title_short Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year
title_sort percutaneous coronary intervention using a full metal jacket with drug-eluting stents: major adverse cardiac events at one year
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998154/
https://www.ncbi.nlm.nih.gov/pubmed/23821408
http://dx.doi.org/10.5935/abc.20130139
work_keys_str_mv AT calerita percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT telesruicampante percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT almeidamanuel percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT dorosarioingrid percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT sousapedrojeronimo percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT britojoao percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT raposoluis percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT goncalvespedrodearaujo percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT gabrielhenriquemesquita percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear
AT mendesmiguel percutaneouscoronaryinterventionusingafullmetaljacketwithdrugelutingstentsmajoradversecardiaceventsatoneyear